Navigation Links
Lilly Reports Third-Quarter 2011 Results
Date:10/20/2011

oping a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers – through medicines and information – for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com; Lilly's clinical trial registry is available at www.lillytrials.com.

F-LLY

This press release contains forward-looking statements that are based on management's current expectations, but actual results may differ materially due to various factors. There are significant risks and uncertainties in pharmaceutical research and development. There can be no guarantees with respect to pipeline products that the products will receive the necessary clinical and manufacturing regulatory approvals or that they will prove to be commercially successful. Pharmaceutical products can develop unexpected safety or efficacy concerns. The company's results may also be affected by such factors as competitive developments affecting current products; market uptake of recently-launched products; the timing of anticipated regulatory approvals and launches of new products; regulatory actions regarding currently marketed products; issues with product supply; regulatory changes or other developments; regulatory compliance problems or government investigations; patent disputes; changes in patent law or regulations related to data-package exclusivity; other litigation involving current or future products; the impact of governmental actions regarding pricing, importation, and reimbursement for pharmaceuticals, including U.S. health care reform; changes in tax law; asset impairments and restructuring charges; acquisitions and business development transactions; and the impact of exchange rates and global
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Lilly Declares Fourth-Quarter 2011 Dividend
2. Lilly Announces Changes in Senior Management
3. Lilly Confirms Date and Conference Call for Third-Quarter 2011 Financial Results Announcement
4. Lilly Improves Its Environmental Footprint in Business Operations and Helps Beautify Communities
5. Eli Lilly and Company Bringing Diabetes Education Program to the Annual Legislative Conference
6. Lilly Celebrates 17th Consecutive Year as One of Working Mother 100 Best Companies
7. Lilly Health Channel Debuts on YouTube
8. Boehringer Ingelheim and Lilly to Feature Type 2 Diabetes Research in Presentations at the 47th Annual Meeting of the European Association for the Study of Diabetes
9. The American Diabetes Association and Eli Lilly and Company Encourage African Americans to Learn About Diabetes Through a Familiar Face
10. Lilly Announces Review of Data on Long-Term Raloxifene Treatment for Postmenopausal Osteoporosis Published in Current Medical Research & Opinion
11. U.S. Court of Appeals Affirms Validity of Lillys Strattera Patent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market ... is an autoimmune disease that permanently destroys beta cells of ... longer produce insulin. Over the last 90 years, insulin therapy ... can be offered to a patient who is newly diagnosed ... of action - long-acting as well as short or rapid-acting ...
(Date:5/27/2015)... 27, 2015 PharmaPoint: Systemic Lupus Erythematosus and ... to 2022 - Event-Driven Update Summary ... GlaxoSmithKline,s Benlysta is the only drug that has gained ... Following Benlysta,s launch, patients, uptake has remained low, but ... to grow the lupus market in terms of value ...
(Date:5/27/2015)... , May 27, 2015 ... http://www.researchandmarkets.com/research/bnrjw5/2015_strategies ) has announced the addition of ... Acid Testing Market"  report to their ... , ,Major issues pertaining to the US ... economic, regulatory, demographic, social and technological trends ...
Breaking Medicine Technology:PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023 2PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023 3PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023 4PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update 2PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update 3United States Nucleic Acid Testing Market Strategies 2015-2020 2
(Date:5/27/2015)... (PRWEB) May 28, 2015 Throughout the past ... site for research comparing the validity and reliability of the ... Preeti Nair, P.T., Ph.D., Associate Professor in the Department of ... for the study. , The Shaw Gait Assessment is a ... of equipment. The GaitRite is considered the gold standard ...
(Date:5/27/2015)... StatRad, a leading provider of cloud-based ... introduce Mr. Chris E. Hafey as its new Chief ... record of leading new development projects and has extensive ... recently served as the Chief Technology Officer for OnPoint ... Architect for Vital Images. , "I am very excited ...
(Date:5/27/2015)... Khanna Vision Institute (KVI) announced the launch ... on keratoconus eye disease . Keratoconus is commonly known ... onset in the teenage years. It worsens over the next ... clear part of the eye is defective. It becomes thin ... results in poor vision which cannot even be corrected with ...
(Date:5/27/2015)... Arizona (PRWEB) May 27, 2015 Continuing ... mission of healthier patients in the community, SmartPractice® ... Center (formerly John C. Lincoln). SmartPractice Vice President of ... Michelle Shaw presented a $25,000 check to Paulla Miller, ... HonorHealth’s Breast Health & Research Center on April 30. ...
(Date:5/27/2015)... CT (PRWEB) May 27, 2015 Dr. ... Institute based in Stamford, CT has been selected as ... the first physicians nationwide (and the only physician in ... injectable which allows for the removal of submental fat ... to no recovery time, no surgery and minimal risks. ...
Breaking Medicine News(10 mins):Health News:Push to Walk Partners with Seton Hall University for Study 2Health News:StatRad Introduces Mr. Chris E. Hafey as Chief Technology Officer, and the Release of its Advanced Pure HTML5 DICOM Image Uploader 2Health News:KVI announced the launch of The Keratoconus website focused on age based keratoconus treatment . 2Health News:SmartPractice Donates $25,000 to HonorHealth Breast Health and Research Center 2Health News:Connecticut Skin Institute First in Connecticut to Offer New Surgery-Free “Double Chin” Fat Reduction Treatment 2Health News:Connecticut Skin Institute First in Connecticut to Offer New Surgery-Free “Double Chin” Fat Reduction Treatment 3
... network of collaborative research. Building on a tool that was ... of Brain , Dr. Yaniv Assaf of Tel Aviv ... of scientists to understand how different parts of the human ... "brain atlas." Brain researchers already know that autism and ...
... as young as four weeks old are being fed a ... new Australian research. A study published in the journal ... been introduced to high fat, salt and sugar foods, despite ... Researcher Jane Scott and colleagues tracked 587 women ...
... Gardner HealthDay Reporter , MONDAY, Sept. 6 ... and proteins from vegetable sources rather than meats is ... types of diets over two decades, researchers found that ... death from cardiovascular disease and cancer, and a lower ...
... About 17 percent of all visits to hospital emergency ... retail medical clinics or urgent care centers, potentially saving ... a new RAND Corporation study. Conditions that could ... fractures and lacerations, according to findings published in the ...
... of California, San Diego School of Medicine have shown ... examining dynamic geometric patterns than they do looking at ... either typical or developmentally delayed toddlers. The results ... patterns early in life may be a signature behavior ...
... a combination of medication and a psychosocial intervention appear ... improved insight, quality of life and social functioningthan those ... September issue of Archives of General Psychiatry , ... the mainstay of therapy for patients with schizophrenia, but ...
Cached Medicine News:Health News:Mapping a brain atlas 2Health News:What are babies made of? Research shows for some it is sugar, salt and not all things nice 2Health News:Low-Carb Diets Heavy on Meat May Raise Health Risks 2Health News:Many hospital emergency department visits could be treated elsewhere, study finds 2Health News:Many hospital emergency department visits could be treated elsewhere, study finds 3Health News:Visual pattern preference may be indicator of autism in toddlers 2Health News:Visual pattern preference may be indicator of autism in toddlers 3Health News:Combining medication and psychosocial treatments may benefit patients with early-stage schizophrenia 2
... Experience the finest surgical-quality loupes ... set the standard for innovative optical ... support. Delivering optimum performance with maximum ... choice for medical professionals worldwide. Make ...
... the finest surgical-quality loupes available ... standard for innovative optical design, combining ... optimum performance with maximum comfort, SheerVision ... medical professionals worldwide. Make both a ...
... SheerVision manufactures its signature line of award-winning ... Frame. These next generation loupes feature ... design, and are multi-coated lens for anti-glare, ... SV Sport frame offers a stylish, yet ...
... FireFly LED light offers superior illumination in ... FireFly LED you'll get powerful, long-lasting illumination ... practice demands. High center-beam brightness and hands-free ... while the rechargeable battery provides over five ...
Medicine Products: